NCCM
ATHE

Nine Chapters Capital Management’s Alterity Therapeutics ATHE Stock Holding History

Nine Chapters Capital Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-175
Closed -$9K – 51
2015
Q3 		$9K Buy
+175
New +$11.1K ﹤0.01% 972
2015
Q2 		– Sell
-248
Closed -$17K – 956
2015
Q1 		$17K Buy
248
+80
+48% +$6.38K ﹤0.01% 940
2014
Q4 		$17K Buy
+168
New +$18.2K ﹤0.01% 904
2014
Q3 		– Sell
-265
Closed -$36K – 988
2014
Q2 		$36K Buy
+265
New +$30.2K ﹤0.01% 912

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Nine Chapters Capital Management's ATHE Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Alterity Therapeutics (ATHE) in Q4 2015, closing a stake of 175 shares — an estimated $9K sold.

Nine Chapters Capital Management first reported a position in ATHE in Q2 2014 and held it in 4 quarters. The position peaked at $36K in Q2 2014. 24 funds tracked by Wall St. Rank hold ATHE as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Alterity Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 175 Alterity Therapeutics shares in Q4 2015, an estimated $9K.
  • Nine Chapters Capital Management first reported a position in Alterity Therapeutics in Q2 2014 and held it in 4 quarters.
  • Nine Chapters Capital Management's Alterity Therapeutics position peaked at $36K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.